Results 201 to 210 of about 2,415,155 (359)
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef+10 more
wiley +1 more source
Human PBMC-based humanized mice exhibit myositis features and serve as a drug evaluation model. [PDF]
Nishidate A+10 more
europepmc +1 more source
Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation. [PDF]
Higashi-Kuwata N+7 more
europepmc +1 more source
Studies on Methods for Evaluation of Anticoccidial Drugs in Vitro
Keizaburo ITAGAKI+2 more
openalex +2 more sources
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon+13 more
wiley +1 more source
Lung cancer organoid-based drug evaluation models and new drug development application trends. [PDF]
Lee E+13 more
europepmc +1 more source
Rolig, Peng, and colleagues have shed new light on how dual blockade of PD1 and LAG3 enhances antitumor immunity. They found that response to immunotherapy with anti‐PD1 + anti‐LAG3 was associated with reprogramming of canonically suppressive CD4+ regulatory T cells to an inflammatory state.
Tullia C. Bruno, Anthony R. Cillo
wiley +1 more source
Construction of a lung cancer 3D culture model based on alginate/gelatin micro-beads for drug evaluation. [PDF]
Zhao Z+10 more
europepmc +1 more source